Drug Information

Drug General Information
Drug ID
D0Z2FX
Former ID
DIB011451
Drug Name
AL-209
Synonyms
SAL; ADNF-9
Indication Central nervous system disease [ICD10:G00-G99] Investigative [531541]
Company
Allon Therapeutics Inc
Canonical SMILES
N1([C@@H](CCC1)C(=O)N[C@H](C(=O)O)C)C(=O)[C@@H](NC(=O)[<br />C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@<br />H](NC(=O)[C@H](CO)N)C)CC(C)C)CC(C)C)CCCNC(=N)N)CO)[C@H]<br />(CC)C
Target and Pathway
Target(s) Tubulin Target Info Modulator [531541]
References
Ref 531541Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects. Curr Pharm Des. 2011;17(25):2603-12.
Ref 531541Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects. Curr Pharm Des. 2011;17(25):2603-12.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.